These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35934980)

  • 1. The incidence and prevalence of motor neurone disease in South Australia.
    Luker J; Woodman R; Schultz D
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
    McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S
    Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of motor neurone disease in two counties in the southwest of England.
    Imam I; Ball S; Wright D; Hanemann CO; Zajicek J
    J Neurol; 2010 Jun; 257(6):977-81. PubMed ID: 20094727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of motor neurone disease in Scotland.
    Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
    J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
    Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
    BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An all-Ireland epidemiological study of MND, 2004-2005.
    Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
    Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4-year prospective study.
    Henning F; Heckmann JM; Naidu K; Vlok L; Cross HM; Marin B
    Eur J Neurol; 2021 Jan; 28(1):81-89. PubMed ID: 32888367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the incidence of motor neuron disease higher in French military personnel?
    Vlaar T; Elbaz A; Moisan F
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):107-115. PubMed ID: 31621421
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of motor neurone disease and multiple sclerosis is different in Estonians and Russians. Data from South Estonia.
    Gross-Paju K; Oöpik M; Lüüs S; Kalbe I; Kaasik AE
    Eur J Neurol; 1999 Mar; 6(2):187-93. PubMed ID: 10053231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Burden of Motor Neuron Disease: An Analysis of the 2019 Global Burden of Disease Study.
    Park J; Kim JE; Song TJ
    Front Neurol; 2022; 13():864339. PubMed ID: 35528743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charity financial support to motor neuron disease (MND) patients in Greater London: the impact of patients' socioeconomic status-a cross-sectional study.
    Gkiouleka A; Manning A; Smith D; Malaspina A; Gallo V
    BMJ Open; 2019 Feb; 9(2):e022462. PubMed ID: 30760512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide incidence of motor neuron disease using the French health insurance information system database.
    Kab S; Moisan F; Preux PM; Marin B; Elbaz A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of multimorbidity and its impact on survival in people with motor neuron disease.
    Glasmacher SA; Kearns PKA; Larraz J; Stirland L; Mehta AR; Newton J; Weir CJ; Chandran S; Pal S;
    Eur J Neurol; 2021 Aug; 28(8):2756-2765. PubMed ID: 34036680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture.
    Fong KY; Yu YL; Chan YW; Kay R; Chan J; Yang Z; Kwan MC; Leung KP; Li PC; Lam TH; Cheung RT
    Neuroepidemiology; 1996; 15(5):239-45. PubMed ID: 8878076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor neurone disease in South Estonia. Diagnosis and incidence rate.
    Gross-Paju K; Oöpik M; Lüüs SM; Kalbe I; Puksa L; Lepik T; Kaasik AE
    Acta Neurol Scand; 1998 Jul; 98(1):22-8. PubMed ID: 9696523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia.
    Phua CS; Ng A; Brooks C; Harrington Z; Vedam H; Huynh T; Seccombe D; Aouad P; Cordato D
    Postgrad Med J; 2021 Sep; 97(1151):566-570. PubMed ID: 32788311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.